Pharmability logo

Pharmability jobs and careers

Sweden

As of October 23, 2026, Pharmability has no open roles listed.

About Pharmability

Pharmability originated from a pivotal scientific discovery made at the Karolinska Institutet, where Professor Anna-Lena Spetz uncovered the unique immunomodulatory potential of a single-stranded oligonucleotide, now known as TIR-01. Unlike conventional therapies that broadly suppress the immune system, TIR-01 demonstrated the ability to modulate immune responses with precision, laying the groundwork for a new class of treatments for autoimmune and inflammatory diseases. This novel mechanism of action opened the door to developing safer and more targeted therapies, an approach that has become central to TIRmed's mission. Since its founding in 2018, the company has made significant strides, advancing from academic research into preclinical and early-stage clinical development. Backed by a syndicate of leading life science investors, TIRmed is now well-positioned to bring its first product candidate, TIR-C, toward clinical validation. Our vision remains focused: to develop innovative therapies that address the unmet needs of patients while redefining the treatment landscape for immune-mediated conditions.

Employees
1 to 10
Headquarters
Sweden

Jobs at Pharmability

No open positions right now. Explore more companies on TheJobsMap.

Pharmability jobs: common questions

Is Pharmability hiring right now?
Pharmability has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Pharmability's careers site.
Where is Pharmability headquartered?
Pharmability is headquartered in Sweden.
How do I apply for a job at Pharmability?
Pick a role on Pharmability's TheJobsMap page and select Apply. Every listing links to the original posting on Pharmability's own careers site, so you apply directly with the employer.